Oral GLP-1 receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and ...

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

GLP-1s have been game-changers for people looking to manage their blood sugar and lose weight. But there’s an obvious downside that’s a deal-breaker for some: You have to inject yourself with the ...

After keeping the faith when it failed in the Modify phase III trial in October 2021, Idorsia Ltd. now has a clear route to market for lucerastat, an oral therapy for Fabry disease.

Oral medication administration in older adults encompasses a range of challenges and innovative solutions aimed at improving therapeutic outcomes in an ageing population. Age-related physiological ...

Monash University and Seaport Therapeutics have developed a new approach to delivering drug molecules that piggybacks onto natural fat absorption ...